The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...

The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.

Study finds low peripheral blood lymphocyte count at diagnosis predicts worse overall survival in multiple myeloma patients.

A mixed methods evaluation of the Canopy Cancer Collective’s implementation of network-wide screening initiative in 2023.

Reduced systemic exposure of Abe minimized the incidence of lymphopenia and hepatic toxicity. In addition, researchers found that although Abe could upregulate expression of indoleamine 2 ...

Researchers conducted a retrospective study to examine the relationship between absolute lymphocyte count (ALC) trajectory and clinical outcomes, and the factors associated with lymphopenia in severe ...